Orthofix Medical Inc. (NASDAQ:OFIX) Insider Jorge Andres Cedron Sells 3,816 Shares

Orthofix Medical Inc. (NASDAQ:OFIX - Get Free Report) insider Jorge Andres Cedron sold 3,816 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $13.31, for a total value of $50,790.96. Following the transaction, the insider now owns 42,500 shares of the company's stock, valued at $565,675. This trade represents a 8.24 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Orthofix Medical Stock Up 2.2 %

Shares of OFIX traded up $0.29 during midday trading on Wednesday, reaching $13.43. 240,902 shares of the stock were exchanged, compared to its average volume of 258,165. The company has a current ratio of 2.39, a quick ratio of 1.11 and a debt-to-equity ratio of 0.25. The company's 50 day moving average is $15.94 and its two-hundred day moving average is $17.10. The company has a market capitalization of $524.07 million, a P/E ratio of -4.29 and a beta of 0.99. Orthofix Medical Inc. has a 52 week low of $12.08 and a 52 week high of $20.73.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. StockNews.com upgraded Orthofix Medical from a "hold" rating to a "buy" rating in a research report on Tuesday, February 25th. Roth Mkm reiterated a "buy" rating and set a $22.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, Canaccord Genuity Group restated a "buy" rating and issued a $24.00 target price on shares of Orthofix Medical in a research note on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Orthofix Medical has a consensus rating of "Buy" and an average price target of $23.33.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Lazard Asset Management LLC purchased a new stake in shares of Orthofix Medical in the 4th quarter worth approximately $45,000. R Squared Ltd purchased a new stake in Orthofix Medical during the fourth quarter worth $50,000. KLP Kapitalforvaltning AS bought a new stake in Orthofix Medical during the 4th quarter valued at $112,000. Tower Research Capital LLC TRC increased its holdings in shares of Orthofix Medical by 120.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,458 shares of the medical device company's stock valued at $148,000 after acquiring an additional 4,627 shares during the period. Finally, State of Wyoming raised its position in shares of Orthofix Medical by 206.8% in the 4th quarter. State of Wyoming now owns 9,432 shares of the medical device company's stock worth $165,000 after acquiring an additional 6,358 shares in the last quarter. 89.76% of the stock is currently owned by institutional investors.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.